06/02/2026
Great connecting with clinical trial leaders at OCT East.
One idea from Linda Kerrigan stuck with us:
"Fast. Cheap. Quality. Pick two."
She noted that when pharma companies are forced to choose, quality and speed consistently rank above cost. We couldn't agree more.
In esoteric and specialized testing, cutting corners on quality isn't a tradeoff. It's a risk. When the science is complex and the stakes are high, sponsors need a lab partner that delivers both precision and speed ā without compromise.